Recce Pharmaceuticals Ltd RECEF
0.22 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
0.60 Day range 0.60
0.22 52-week range 0.60
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 67.29M
- EPS (ttm)
- -0.06
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 60
- Open
- 0.60
- Previous close
- 0.22
- Day's range
- 0.60 – 0.60
- 52-week range
- 0.22 – 0.60
2Y -0.3800 (-63.33%)
News
Recce Pharmaceuticals signs Arrotex deal for RECCE 327 in Australia and New Zealand 
Recce Pharmaceuticals advances Phase 3 diabetic foot infection trial to independent data review 
Snowflake shares surge after Q2 beat, raised guidance 
Polymarket valuation hits $21bn as Trump Jr's firm leads $1bn round 
Baidu misses Q2 revenue and earnings estimates as core business slips 
Bank of England holds rates but three dissenters vote for hike 
Recce Pharmaceuticals positioned for US$66.9 billion US biodefence strategy 
Recce Pharmaceuticals advances dual Phase 3 programs and MENA licensing strategy in strong June quarter 
Twilio faces higher bar heading into quarterly earnings, says Jefferies 
Halliburton tops Q2 earnings estimates as CEO warns of softer oilfield services market
Your note
Sign in to keep a note on RECEF — it syncs with the Stock Master app.